General MedicationsORALGeneric

PRINZIDE

HYDROCHLOROTHIAZIDE; LISINOPRIL

Standard Dose

12.5MG;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview PRINZIDE is listed in Drugs@FDA under application 019778 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; LISINOPRIL Form and strength TABLET;ORAL - 12.5MG;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MERCK Submission history Latest submission status date: 2013-02-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview PRINZIDE is listed in Drugs@FDA under application 019778 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROCHLOROTHIAZIDE; LISINOPRIL Form and strength TABLET;ORAL - 12.5MG;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MERCK Submission history Latest submission status date: 2013-02-26 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.